Invesco Biotechnology & G... (PBE)
NYSEArca: PBE
· Echtzeitkurs · USD
93.47
-0.75 (-0.80%)
Zum Schluss: Aug 14, 2026, 9:46 AM
Invesco Biotechnology & Genome ETF (PBE) ETF Price, Holdings & Analysis
-0.80% (1D)
| Geld | 93.05 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 281.95 Mio |
| NAV | 93.86 |
| Beta | 0.79 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 25.15 |
| Ausstehende Anteile | 4.55 Mio |
| Auflagedatum | Jun 23, 2005 |
| Brief | 93.29 |
| Volumen | 159 |
| Ø Vol. (20D) | 22,217 |
| Eröffnung | 93.47 |
| Vortagesschluss | 94.22 |
| Tagesspanne | 94.08 - 94.67 |
| 52-Wk Range | 67.05 - 95.01 |
| Positionen | k.A. |
| Kostenquote | 0.58% |
Über PBE
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Anlageklasse Equity
Tickersymbol PBE
Auflagedatum Jun 23, 2005
Anbieter Invesco
Website Fonds-Homepage
Börse NYSEArca
Top 10 Positionen 46.14% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Regeneron Pharmaceut... | REGN | 5.47% |
| Amgen Inc | AMGN | 5.22% |
| Caredx Inc | CDNA | 5.03% |
| Vertex Pharmaceutica... | VRTX | 4.98% |
| Royalty Pharma PLC C... | RPRX | 4.93% |
| Biogen Inc | BIIB | 4.78% |
| Gilead Sciences Inc | GILD | 4.43% |
| United Therapeutics ... | UTHR | 4.07% |
| Bio-techne Corp | TECH | 3.73% |
| Illumina Inc | ILMN | 3.50% |
Dividenden Dividendenrendite 1.66%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jun 22, 2026 | $0.8110 | k.A. |
| Mar 23, 2026 | $0.0820 | k.A. |
| Dec 22, 2025 | $0.4200 | k.A. |
| Sep 22, 2025 | $0.2340 | k.A. |
| Jun 23, 2025 | $0.1300 | k.A. |
